Recent estimates suggest that 3.3 million children worldwide are living with human immunodeficiency virus (HIV), of whom 2.9 million live in sub-Saharan Africa. 1 Most children acquire HIV through vertical transmission and, in some cases, the virus can cause neurological damage and malfunction within the developing central nervous system (CNS). The most common manifestation of HIV CNS infection is HIV encephalopathy (HIVE), an acquired immune deficiency syndrome (AIDS)-defining condition diagnosed on the basis of at least one of the following criteria, present for at least 2 months: (1) failure to attain developmental milestones or loss of those previously attained; (2) impaired brain growth or acquired microcephaly; or (3) motor deficits such as pathological reflexes or gait disturbances. 2 Highly active antiretroviral therapy (ART) can substantially decrease the incidence of HIVE among perinatally infected children. 3, 4 However, not all children may have received treatment, or may have started ART too late to protect against neurological damage. 3, 5, 6 This is often the case in resource-limited settings such as South Africa, where only 32% to 49% of HIV-infected children received ART between 2011 and 2014. 7 These factors may help to explain why HIVE remains a current concern in resource-limited settings. 6 For example, a recent report from the Red Cross War Memorial Children's Hospital (RCWMCH) in Cape Town showed that 87 out of 145 children who attended a dedicated HIVneurology clinic between 2008 and 2012 were diagnosed with HIVE according to Centres for Disease Control criteria. 6 Furthermore, 55 (63%) of these children presented with bilateral lower limb (BLL) spasticity, which is believed to reflect more severe HIVE cases. 6 BLL spasticity appears to be the most common motor deficit associated with HIVE, 3, 8, 9 and the first description of gait pattern in this population was recently published. 9 However, as yet little is known about holistic, day-to-day function in children with HIVE and BLL spasticity. For example, it is unclear whether this condition is also associated with impairments in upper limb motor function, which may have been previously overlooked. Furthermore, the effects of HIVE and BLL spasticity on day-to-day activities and participation have not been described.
Therefore, the main aim of the current study was to provide insight into the functional status of children with HIVE and BLL spasticity, receiving ART, by describing (1) upper limb motor function, assessed using the Purdue Pegboard, and (2) level of activity and participation, assessed using the Paediatric Evaluation of Disability Inventory (PEDI), compared with typically developing children. A secondary aim of the study was to assess to what extent limitations in upper limb motor function, activity, or participation were related to the severity of gross motor function impairment, on the basis of Gross Motor Classification System (GMFCS) level.
METHOD Participants
Children with BLL spasticity as part of a HIVE diagnosis and typically developing children were recruited for this cross-sectional study, over the course of 2014. Children potentially eligible for the HIVE group were recruited through a database of children seen at an HIV-neurology clinic at RCWMCH, referrals from clinicians at RCWMCH and at Tygerberg Hospital, and from special needs schools within the Cape Town area. The typically developing group was comprised of a convenient sample recruited through existing study participants and contacts of the researchers. This group was matched to the HIVE group for age and sex distribution, and was comprised of children from a similar socioeconomic background and geographical area within Cape Town as the HIVE group.
Criteria for inclusion in the HIVE group were (1) 5 to 12 years of age, (2) a diagnosis of HIVE according to Centres for Disease Control criteria, 2 (3) increased muscle tone in the lower limbs, and (4) ambulant with or without the use of walking aids. Exclusion criteria for the HIVE group were (1) significant prematurity (birth weight ≤2.0kg and/ or a gestational age of ≤35wks), (2) additional neuromuscular or CNS disorders (e.g. previous tuberculosis meningitis), (3) botulinum neurotoxin treatment within the last 6 months, or (4) orthopaedic surgery on the lower limbs within the previous 12 months.
Criteria for inclusion in the typically developing group were (1) normal walking and running gait pattern, (2) no known diagnosis of HIV, (3) no formal diagnosis of a learning, psychiatric, neurological, or developmental condition, (4) no previous head injuries that resulted in loss of consciousness and/or hospitalization, and (5) no previous surgery on the lower limbs.
The study was approved by the Human Research Ethics Committee of the University of Cape Town (HREC 447/ 2012) and by RCWMCH. Each parent or caregiver provided written informed consent before their child's participation and assent was sought from the participant themselves when age appropriate. An isiXhosa translator assisted as necessary when completing informed consent or questionnaires with the caregiver and completing assessments with the participant.
Outcome measurements
Clinical and demographic background information was obtained through an interview with the participant's caregiver and a review of the participant's medical record. Each participant's height and weight on the day of the assessment were recorded and used to calculate body mass index. Housing density, as an indicator of socioeconomic status, was taken as the number of rooms in the home (excluding the kitchen and bathroom) divided by the number of people living in the home. 10 Each child with HIVE and BLL spasticity was classified according to the GMFCS, a 5-level scale conventionally used to describe current functional status in children with cerebral palsy. 11 GMFCS levels applicable for the current study were GMFCS level I (highest ability, 'walks without limitations'), GMFCS level II ('walks with limitations'), and GMFCS level III ('walks with a hand-held mobility device'). Participants were also classified according to the Manual Ability Classification System, a 5-level scale used to describe how children with cerebral palsy handle objects during daily activities. Manual Ability Classification System levels applicable for the current study were level I ('handles objects easily and successfully') and level II ('handles most objects but with somewhat reduced quality and/or speed of achievement'). 12 Upper limb motor function (including upper limb motor coordination and fingertip dexterity) was assessed using the Purdue Pegboard, 13 a timed assessment in which children place metal pins into holes as quickly as possible over a series of four tests. For the first three tests, children were scored on the basis of the number of pins placed within a 30-second period using the preferred hand only, the nonpreferred hand only, and both hands, bilaterally. For the fourth test, children used alternate hands to construct 'assemblies' of pins, washers, and collars and were scored according to the number of pieces placed within 1 minute. Raw scores were converted into age-and sex-specific zscores based on the US population-based normative data of Gardner and Broman. 14 Level of activity and participation was measured using the Computer-Adapted Pediatric Evaluation of Disabilities Inventory (PEDI-CAT). This assessment is based on caregiver responses and is designed to assess day-to-day What this paper adds
• Some children with human immunodeficiency virus encephalopathy (HIVE) and bilateral lower limb (BLL) spasticity have limitations in upper limb function.
• Upper limb function was often related to lower limb function.
• Poor upper limb function was particularly prevalent in children in Gross Motor Function Classification System (GMFCS) level III.
• Social/cognitive function was lower than in typical developing children, but not related to GMFCS level.
• Level of responsibility was similar for children with HIVE and BLL spasticity and typical developing children.
function in children and young people with a variety of diagnoses. 15, 16 Level of activity was measured using the Daily Activities, Mobility, and Social/Cognitive domains of the PEDI-CAT whereas participation was measured using the Responsibility domain. The 'speedy' version of the PEDI-CAT was completed in the form of a structured interview with the child's parent or caregiver and reported as a T score for each of the four domains assessed. A T score of 50 (SD 10) represents the mean score and SD for a particular age group in the US population-based normative sample (in 1y intervals), hence T scores between 30 and 70 (mean 2SD) could be considered within normal range. 17 
Statistical analysis
All variables are reported as median and interquartile range unless otherwise stated. Outcome measures in the pooled HIVE and typically developing groups were compared using a Mann-Whitney test. The HIVE group was subsequently divided into GMFCS level I, II, and III groups to examine the effect of gross motor ability on the outcome measurements. Differences between the three GMFCS level groups and the typically developing group were investigated using a Kruskal-Wallis test and Dunn's post-hoc test. All statistical analyses were completed using GraphPad Prism version 6 (GraphPad Software, La Jolla California USA; www.graphpad.com) with significance accepted at p<0.05.
RESULTS Participants
Thirty children who met the criteria for the HIVE group and 20 children who met the criteria for the typically developing group were enrolled in the study. The HIVE group was comprised of 14 males and 16 females with a median age of 8y 3mo (range 5y 1mo-12y 10mo), all of whom were receiving ART at the time of assessment. The typically developing group was comprised of 11 males and nine females with a median age of 8y 4mo (range 5y 10mo-12y 11mo). Further demographic and clinical information for the HIVE and typically developing groups is presented in Table I .
Pooled HIVE group versus typically developing group
Purdue Pegboard z-scores were significantly lower in the HIVE group than in the typically developing group across all four pegboard tasks (p≤0.001; Table II ). PEDI-CAT T scores were also significantly lower in the HIVE group than in the typically developing group for the Daily Activities, Mobility, and Social/Cognitive domains of the PEDI-CAT (p<0.001; Table II ). However, there was no significant difference in the Responsibility domain T scores when comparing the HIVE and typically developing groups.
HIVE GMFCS levels versus typically developing group
When the HIVE participants were divided according to GMFCS level, only the GMFCS level III group consistently showed significantly lower z-scores than the typically developing group across all four pegboard tasks (p<0.015; Fig. 1 ). PEDI-CAT responses also differed by GMFCS level. For example, participants in GMFCS level I showed significantly lower T scores than the typically developing participants for the Mobility domain (p<0.002; Fig. 2b ) and the Social/Cognitive domain (p<0.003; Fig. 2c ), but not for the Daily Activities domain (Fig. 2a) . In contrast, participants in GMFCS levels II and III showed significantly lower T scores than the typically developing group for the Daily Activities domain as well as for the Mobility and Social/Cognitive domains (p<0.004; Fig. 2a-c) . In keeping with the pooled HIVE versus typically developing group observations (Table II) , there were no significant differences in Responsibility domain T score when comparing the GMFCS level I, II, and III and typically developing groups (Fig. 2d) .
Individual responses
Individual scores for both Purdue Pegboard tasks and PEDI-CAT domains varied substantially within each of the GMFCS level groups (Figs. 1 and 2 ). When individual scores from all GMFCS levels were pooled and ranked in order of magnitude, most outcomes showed a mixing of GMFCS levels, with GMFCS levels I, II, and III represented among both the highest and lowest outcome scores (Fig. 3) . The two exceptions to this were the pegboard task involving both hands and the Mobility PEDI-CAT domain (Fig. 3c, f) , in which individuals in GMFCS level III contributed most of the lowest scores.
DISCUSSION Upper limb function and daily activities
The first finding of the current study was that some children with HIVE and BLL spasticity had significant impairments in upper limb motor function over and above the established impairments in lower limb motor function. This finding was based on significantly lower Purdue Pegboard z-scores when comparing the HIVE and typically developing groups, as well as significantly lower T scores for the Daily Activities domain of the PEDI-CAT (Table II) . These outcomes are somewhat complementary in that the Purdue Pegboard reflects fine motor performance in a timed, structured activity and the Daily Activities domain reflects ability in day-to-day tasks that 'require coordination and discrete movements of the hands and arms' (e.g. activities related to eating and dressing). 17 Although there were clear differences at a group mean level, there was noticeable individual variation in the scores of the HIVE participants and it was apparent that upper limb motor performance was somewhat related to the severity of gross motor impairments (Fig. 3) . For example, when the HIVE group was divided according to GMFCS level, the mean GMFCS level III score was significantly lower than the mean score of the typically developing group across all upper limb motor function outcomes, whereas mean GMFCS level II scores were only significantly lower for certain outcomes and mean GMFCS level I scores were not significantly different from those of the typically developing group (Figs. 1 and 2a) .
The largest differences in Purdue Pegboard z-score between GMFCS level III and the typically developing group were for tasks involving both hands, which suggests that deficits in upper limb motor function become more apparent in tasks requiring increased coordination and dexterity. Furthermore, these bilateral tasks did not allow the child to rest an arm on the table for support, which suggests that the association between gross motor function and upper limb function may be partly related to core stability. For example, a previous study in children with spastic cerebral palsy showed that a botulinum neurotoxin injection to the lower limbs resulted in improved upper limb motor function, including functional ability in daily activities related to self-care. 18 As discussed by the authors, 18 reduced lower limb spasticity after the injection may have allowed for more effective muscle recruitment, including stabilization of the pelvis and postural control of the trunk. In a similar way, the extent of lower limb involvement and relative core stability may have influenced upper limb motor performance among the current participants, and therefore may partly explain the low scores among those in GMFCS level III.
Nevertheless, the broad relationship between poor lower limb motor function and poor upper limb motor function did not hold for all individuals and there was a noticeable range in Purdue Pegboard and Daily Activity scores within all GMFCS level groups. In the case of the Purdue Pegboard, the child's ability to focus and follow instructions for a potentially unfamiliar activity, in a structured environment, may also influence the score obtained. It is possible that cognitive factors may have contributed to some of the individual variation observed. Nevertheless, it is important to note that some children in all three GMFCS levels had scores less than À2SD below the ageand sex-adjusted mean (Figs. 1 and 3a-d) . These normative data were based on a US population, 14 and it is likely that the normative mean and SD values would differ somewhat in a South African setting. Nevertheless, many individual scores from children with HIVE fell below both the US normal range and the range of individual typically developing responses, which suggests that, in some cases, upper limb motor function is not simply lower than that of typically developing children but in fact meaningfully impaired.
It is unclear whether impairments in upper limb motor function are more common or more severe in children with HIVE and BLL spasticity than in children with a different AIDS-defining condition. In a previous report of upper limb motor function in children with HIV, Blanchette et al. 19 found significantly reduced fine motor performance in HIV-infected children than in an uninfected comparison group when children with AIDS were included in the participant group. Conversely, others have reported similar fine motor function in HIV-infected children than in an uninfected comparison group when the participants had no previous diagnosis of an AIDS-defining condition. 20, 21 Nevertheless, the first finding of the current study suggests that routine clinical assessment of a child with HIVE and BLL spasticity should include an evaluation of upper limb as well as lower limb motor function.
Mobility
A further finding of the current study was that most children with HIVE and BLL spasticity had significant impairments in mobility, even when able to walk unaided (GMFC levels I and II). This finding was based on a significantly lower score for the Mobility domain of the PEDI-CAT when comparing the HIVE and typically developing groups along with the observation that 26 out of the 30 participants with HIVE had scores less than À2SD below the age-and sex-adjusted mean (Table II and Fig. 2b) . Although all three GMFCS levels had a significantly lower Mobility score than that of the typically developing group, the largest differences were observed for GMFCS levels II and III, confirming a relation between gross motor function and mobility. Although these functional impairments are largely intuitive, they add practical perspective to the gait abnormalities previously described in this population, 9 as well as insight into quality of life for the affected children.
Social/cognitive function
In addition to limitations in upper limb motor function and mobility, the current study also found significantly lower Social and Cognitive function in the HIVE group than the typically developing group, on the basis of this domain of the PEDI-CAT (Table II) . Although some HIV-infected children, receiving ART, may have relatively normal cognitive function, an AIDS-defining illness early in life has been strongly associated with persistent neurocognitive deficits. 22, 23 Furthermore, an early diagnosis of HIVE may have a particularly poor prognosis for subsequent cognitive outcomes, with Smith et al. 23 reporting a significantly increased risk of deficits in processing speed, perceptual reasoning, and general cognitive functioning along with certain adaptive domains in young people with HIVE compared with HIV-infected young people with no previous Centres for Disease Control class C event. While the current findings are broadly consistent with these previous reports, it is interesting to note that children in all three GMFCS levels had significantly lower scores than that of the typically developing group (Fig. 2c) . In other words, this outcome did not appear to be related to gross motor function, with participants in GMFCS levels I and III showing a similar distribution of scores. Nevertheless, the Social/Cognitive domain of the PEDI-CAT and the GMFCS represent broad levels of cognitive and gross motor functions respectively, and future studies could investigate the relation between more specific gross motor function and neurocognitive domains.
Responsibility
On the basis of the differences in upper limb motor function, Mobility, and Social/Cognitive function between the HIVE and typically developing groups, it was surprising to observe no significant differences in the domain of Responsibility (Fig. 2d) . Furthermore, this was the only domain in which all children in the GMFCS level groups had T scores within the normal range and the mean T score for the GMFCS level groups was approximately the same as the mean score in the US-based normative population (Figs 2d and 3h) .
The Responsibility domain assesses the extent to which a child is able to manage tasks independently. It differs from the aforementioned domains in that it asks caregivers to report the proportion by which caregiver and child share responsibility for a task (e.g. caregiver most responsibility vs equal responsibility vs child more responsibility, etc.) rather than how difficult an activity is for the child. In other words, although many functional activities may be more difficult for children with HIVE than for typically developing children, those with HIVE do not appear to have any less responsibility in tasks such as taking care of minor health needs, travelling safely within the community, or following a weekly schedule. This observation may indicate an encouraging resilience and initiative on the part of the children with HIVE. Nevertheless, most of the children with HIVE were from low-resource backgrounds where the caregiver may have long working hours and/or be caring for several children. Therefore, it is also likely that many children assume a level of responsibility comparable to that of their typically developing peers out of necessity rather than choice.
Considerations
Unfortunately, further insight into the early childhood and home life of the HIVE participants fell beyond the scope of the current study. However, it must be acknowledged that some of these factors may have influenced the current outcomes. For example, maternal education level and quality of nutrition during pregnancy along with the child's exposure to stimulation and learning opportunities are among a variety of factors that can impact neurodevelopment. 24, 25 These factors are likely to have contributed to the individual variation in outcomes within both the HIVE and typically developing groups. Furthermore, these factors may have contributed to differences between the HIVE and typically developing groups in that factors contributing to poor neurodevelopment may be more prevalent in families where there is HIV infection. Although the current study did exclude children born prematurely, another factor that may impact neurodevelopment, 25 being unable to account for the potential role of other neurodevelopmental influences is an acknowledged limitation. A further limitation of the study is the relatively small sample size, particularly when dividing the HIVE group according to GMFCS level. This limitation can be attributed primarily to challenges in finding children who met all the criteria for the HIVE group.
Despite these limitations, the current findings have clear relevance for clinical practice because they highlight the potential for poor upper limb motor function and difficulty with daily activities, mobility, and social/cognitive function in children with HIVE and BLL spasticity, even when able to walk unaided. Unfortunately, cases of HIVE and BLL spasticity are more likely to occur in resource-limited settings where additional screening and subsequent therapeutic interventions may be difficult to apply in practice. Nevertheless, to do so may form part of optimal care for children with HIVE and BLL spasticity and help reduce the burden associated with this health condition.
